Lv5
1520 积分 2024-08-12 加入
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
16小时前
待确认
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
2天前
已完结
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
3天前
已完结
Tertiary lymphoid structures in cancer
4天前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
4天前
已完结
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression
4天前
已完结
Tertiary Lymphoid Structures Validated as Biomarker
4天前
已完结
Anatomic Lung Resection Is Associated With Improved Survival Compared With Wedge Resection for Stage IA (≤2 cm) NSCLC
15天前
已完结
Development and Prospective Validation of a Cell-Free DNA–Based Model for the Early Detection of Pancreatic Cancer
15天前
已完结
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
17天前
已完结
皖公网安备34019202002308
